Mercedes-backed ProLogium starts 381 Wh/kg solid-state production as carmakers watch from sidelines

ProLogium Technology has started mass production of its 381 Wh/kg solid-state battery cell, meeting China's GB/T 43568-2026 standard. The company, backed by Mercedes-Benz, aims to scale production but faces cost and volume challenges. Its current capacity is 0.5 GWh, with plans to expand. ProLogium's technology has been tested and certified, but its commercial viability for EVs remains uncertain.

Original reporting
Published Sep 6, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 6, 2026, 1:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mercedes-backed ProLogium starts 381 Wh/kg solid-state production as carmakers watch from sidelines — source image
Decision brief

The 30-second read

Low
01

Why it matters

The announcement marks the first commercial rollout of a high‑energy solid‑state cell, but the small 0.5 GWh initial capacity limits near‑term market impact.

02

Market read

While the technology breakthrough is notable, the limited production scale and lack of cost disclosure constrain immediate trading relevance for listed equities.

03

What to watch

Regulatory standard GB/T 43568 may become a de‑facto benchmark, giving ProLogium early mover advantage if adopted internationally.

Relevance 5/10Novelty 6/10Timing: mass production announced Sep 2, reported Sep 6

Background

ProLogium Technology, a Taiwanese battery developer, announced the start of mass production for its Generation 3.5 solid‑state lithium‑ceramic cell with 381 Wh/kg energy density.

Market effects

demonstrates progress in solid‑state battery tech, may spur further R&D investment in EV battery sector.

boosts Taiwan's battery manufacturing profile and could influence European EV supply chains with the planned French plant.

adds a new competitor to the global solid‑state race, but limited immediate impact on major listed battery makers.

Counterpoint

Without disclosed cost data, the high energy density may not translate into commercial advantage; larger incumbents could maintain lead.

Key entities

  • ProLogium Technology

    Taiwanese solid‑state battery developer launching mass production.

  • Mercedes‑Benz

    Automotive partner in a technology cooperation agreement with ProLogium.

Related articles

Low

ProLogium Technology Co., Ltd.: Mercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium's latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology

Mercedes-Benz and ProLogium have signed a joint testing agreement for ProLogium's Gen4 solid-state battery cells, building on a decade-long partnership. The agreement grants Mercedes-Benz priority access to test the technology, which offers high energy density, safety, and performance. ProLogium plans to go public on NASDAQ in 4Q2026 under the ticker PRLG.

$PRLGMed

ProLogium Ships First Solid-State Cells as Dunkirk Factory Rises

ProLogium Technology has started mass production of its lithium-ceramic battery cells in Taiwan, achieving 381 watt-hours per kilogram. The company is building a €5.2 billion gigafactory in Dunkirk, France, with production expected to begin in 2028. ProLogium aims to list shares on Nasdaq under ticker PRLG via a SPAC merger valued at $3.8 billion. The company has partnerships with Mercedes-Benz and Rimac, and its technology promises higher energy density and improved safety for electric vehicles

$TDACMedAI 8/10

ProLogium Technology Co., Ltd.: ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination

ProLogium and Nasdaq-listed SPAC TDAC said they secured commitments for a $50 million primary capital investment from existing ProLogium shareholders at a pre-money valuation of about $3.8 billion to support their proposed business combination. Proceeds are earmarked for scaling next-generation lithium ceramic batteries and building a Dunkirk, France gigafactory, alongside a French subsidy package up to €1.375 billion.

$MRNAHighAI 8/10

Moderna (MRNA) Surges 37% in September Despite Healthcare Sector

Moderna (MRNA) surged 37.22% in September due to promising Phase 3 results for its personalized mRNA cancer vaccine, outperforming the broader healthcare sector. The company's P/S ratio is 33.44, significantly higher than its historical median of 8.41, reflecting high growth expectations. Moderna remains unprofitable, with a GF Score of 54/100, indicating mixed financial health. Insider activity shows significant selling, while guru ownership is mixed.

$LMTMedAI 8/10

Lockheed Martin in Advanced Talks to Expand Patriot PAC-3 Missile Production Outside

Lockheed Martin is in advanced talks to expand Patriot PAC-3 missile production outside the U.S. to meet global demand, which has tripled. The company aims to increase annual production capacity from 600 to 2,000 interceptors by 2030, investing up to $9 billion. Shortages of Patriot missiles are affecting Ukraine and Middle East conflicts, according to reports. Lockheed is also developing a lower-cost interceptor, PAC-3 ACE.